Skip to main content
. 2021 Feb 1;28(1):372–379. doi: 10.1080/10717544.2021.1879316

Figure 5.

Figure 5.

(a) Antibacterial activity of γ-CD-MOF and drug-loaded γ-CD-MOF. (b) Concentration-time profiles of enrofloxacin in plasma of female rats after a single subcutaneous administration of free enrofloxacin and enrofloxacin-loaded γ-CD-MOF (equivalent to 0.5 mg/kg enrofloxacin).